Lyell Wealth Management LP Reduces Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Lyell Wealth Management LP decreased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.7% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 33,709 shares of the medical equipment provider’s stock after selling 236 shares during the quarter. Intuitive Surgical comprises 1.6% of Lyell Wealth Management LP’s portfolio, making the stock its 14th biggest holding. Lyell Wealth Management LP’s holdings in Intuitive Surgical were worth $17,595,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently modified their holdings of the company. M.E. Allison & CO. Inc. bought a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $449,000. Seilern Investment Management Ltd bought a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $82,517,000. Sycomore Asset Management lifted its stake in shares of Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after acquiring an additional 4,079 shares during the last quarter. Exome Asset Management LLC raised its position in Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after purchasing an additional 1,069 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. raised its position in Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after purchasing an additional 525 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $601.17 on Wednesday. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The stock’s fifty day moving average price is $561.88 and its 200 day moving average price is $522.27. The company has a market cap of $214.12 billion, a price-to-earnings ratio of 93.79, a price-to-earnings-growth ratio of 5.74 and a beta of 1.39.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the company. Raymond James lifted their target price on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Leerink Partners lifted their target price on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Evercore ISI lifted their target price on Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Jefferies Financial Group lifted their target price on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Finally, CICC Research assumed coverage on Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 target price for the company. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Insider Buying and Selling

In related news, CFO Jamie Samath sold 188 shares of the business’s stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $101,332.00. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,720,023. The trade was a 2.10 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 6,348 shares of company stock worth $3,587,582 in the last ninety days. 0.80% of the stock is owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.